Literature DB >> 7559098

Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumor necrosis factor-alpha release in mouse lung tissues.

E Sueoka1, S Nishiwaki, S Okabe, N Iida, M Suganuma, I Yano, K Aoki, H Fujiki.   

Abstract

Cord factors are mycoloyl glycolipids in cell walls of bacteria belonging to Actinomycetales, such as Mycobacterium, Nocardia and Rhodococcus. They induce granuloma formation in the lung and interstitial pneumonitis, associated with production of macrophage-derived cytokines. We studied how cord factors induce biological activities in the cells. Cord factors isolated from M. tuberculosis, trehalose 6-monomycolate (mTMM) and trehalose 6,6'-dimycolate (mTDM), enhanced protein kinase C (PKC) activation in the presence of phosphatidylserine (PtdSer), diacylglycerol and Ca2+, and mTMM activated PKC alpha more strongly than PKC beta or gamma under the same assay conditions. Kinetic studies of mTMM in response to PKC activation revealed that mTMM increased the apparent affinity of PKC to Ca2+ in the presence of both PtdSer and diolein. Although this is similar to observations with unsaturated fatty acids, such as arachidonic acid, mTMM was synergistic with PtdSer for PKC activation, but arachidonic acid was not. mTMM was also different as regards PKC activation, as phorbol ester was. A single i.p. administration of mTMM to mouse induced tumor necrosis factor-alpha (TNF-alpha) in serum and in the lung, which is a unique target tissue of cord factors. Based on our recent finding that TNF-alpha is an endogenous tumor promoter, the correlation between lung cancer and pulmonary tuberculosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559098      PMCID: PMC5920914          DOI: 10.1111/j.1349-7006.1995.tb02464.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  23 in total

1.  Pulmonary tuberculosis and carcinoma of the lung. A survey from two population-based disease registers.

Authors:  R Steinitz
Journal:  Am Rev Respir Dis       Date:  1965-11

2.  Phenotypes of infiltrating cells in trehalose dimycolate-induced interstitial pneumonitis.

Authors:  Y Sakamoto; M B Goren; C H Kirkpatrick
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

3.  Tumor necrosis factor (cachectin) mediates induction of cachexia by cord factor from mycobacteria.

Authors:  C L Silva; L H Faccioli
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

Review 4.  Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid.

Authors:  H Fujiki; M Suganuma
Journal:  J Biochem       Date:  1994-01       Impact factor: 3.387

5.  Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation.

Authors:  A Komori; J Yatsunami; M Suganuma; S Okabe; S Abe; A Sakai; K Sasaki; H Fujiki
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

6.  Granuloma formation and hemopoiesis induced by C36-48-mycolic acid-containing glycolipids from Nocardia rubra.

Authors:  K Kaneda; Y Sumi; F Kurano; Y Kato; I Yano
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Mode of activation and kinetic properties of three distinct forms of protein kinase C from rat brain.

Authors:  K Sekiguchi; M Tsukuda; K Ase; U Kikkawa; Y Nishizuka
Journal:  J Biochem       Date:  1988-05       Impact factor: 3.387

8.  Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids.

Authors:  Y Takai; A Kishimoto; Y Iwasa; Y Kawahara; T Mori; Y Nishizuka
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

Review 9.  Excess incidence of lung cancer among pulmonary tuberculosis patients.

Authors:  K Aoki
Journal:  Jpn J Clin Oncol       Date:  1993-08       Impact factor: 3.019

10.  Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships.

Authors:  Y Natsuhara; S Oka; K Kaneda; Y Kato; I Yano
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more
  7 in total

1.  Modulatory effect of mycobacterium cell wall extract (Regressin) on lymphocyte blastogenic activity and macrophage cytokine gene transcription in swine.

Authors:  S A Vézina; D Archambault
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 2.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

3.  Production of tumor necrosis factor and nitric oxide by macrophages infected with live and dead mycobacteria and their suppression by an interleukin-10-secreting recombinant.

Authors:  B G Marshall; M A Chambers; A Wangoo; R J Shaw; D B Young
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Early secreted antigenic target of 6 kDa (ESAT-6) protein of Mycobacterium tuberculosis induces interleukin-8 (IL-8) expression in lung epithelial cells via protein kinase signaling and reactive oxygen species.

Authors:  Vijay Boggaram; Koteswara R Gottipati; Xisheng Wang; Buka Samten
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

5.  Carcinogenic potential of tobacco tar-resistant Staphylococcus aureus in buccal cavity.

Authors:  H Fujiki; H Takeuchi; N Nishitani; H Yamanaka; K Suzuki; M Kurusu; M Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-11       Impact factor: 4.553

Review 6.  Underestimated Manipulative Roles of Mycobacterium tuberculosis Cell Envelope Glycolipids During Infection.

Authors:  Andreu Garcia-Vilanova; John Chan; Jordi B Torrelles
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

7.  Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle.

Authors:  Eri Ishikawa; Tetsuaki Ishikawa; Yasu S Morita; Kenji Toyonaga; Hisakata Yamada; Osamu Takeuchi; Taroh Kinoshita; Shizuo Akira; Yasunobu Yoshikai; Sho Yamasaki
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.